Budapest, Hungary

Nóra Sziray


Average Co-Inventor Count = 15.5

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2010-2011

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Nóra Sziray: Innovator in Pharmaceutical Chemistry

Introduction

Nóra Sziray is a prominent inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for medical applications. With a total of 2 patents, Sziray's work focuses on improving treatments for various disorders.

Latest Patents

Sziray's latest patents include innovative piperazine derivatives of alkyl oxindoles. This invention is concerned with new indol-2-one derivatives that exhibit a favorable activity profile for the prophylaxis and treatment of disorders in the central nervous and cardiovascular systems. Another notable patent involves piperazine derivatives of dialkyl oxindoles, which are new 3,3-disubstituted indol-2-one derivatives. These compounds are designed to be useful in treating or preventing diseases affecting the central nervous system, gastrointestinal system, and cardiovascular system.

Career Highlights

Nóra Sziray is currently associated with Egis Gyógyszergyár Nyrt, a leading pharmaceutical company in Hungary. His work at Egis has allowed him to focus on the synthesis and application of new pharmaceutical compounds, contributing to advancements in medical treatments.

Collaborations

Sziray has collaborated with notable colleagues, including Balázs Volk and József Barkóczy. These partnerships have fostered a collaborative environment that enhances innovation and research in pharmaceutical chemistry.

Conclusion

Nóra Sziray is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in medical treatments. His innovative patents and collaborations reflect his commitment to improving healthcare through scientific research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…